Filing Flows › Adaptive Biotechnologies (ADPT) › Stock forecast & fair value
Adaptive Biotechnologies (ADPT) stock forecast and price target
Adaptive Biotechnologies (ADPT) trades at $27.98. 7 analysts' median price target is $32.00 (+14%), from $21.00 to $35.00.
Adaptive Biotechnologies' latest quarter
Adaptive Biotechnologies, Q3 2026: revenue $83.9M (-11% year over year), operating margin -0.5%, net earnings $2.8M, operating cash flow $9.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for ADPT stock?
The median of 7 analysts' 12-month targets is $32.00, +14% from $27.98; the range is $21.00 to $35.00. The average rating is strong buy.
Does Adaptive Biotechnologies usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is ADPT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.